
With a trusty pocketknife, you can open a letter, slice an apple, sharpen a pencil. Yet your options increase—or unfold—if you procure a device that contains multiple tools: scissors, a screwdriver, a magnifying glass and other helpful gadgets.
The next-generation lattice light-sheet microscope, or LLSM, is the high-tech version of a handy tool with more than one function. The term lattice explains the intersection of ultra-thin sheets of laser light; the equipment will also feature adaptive optics, a technology borrowed from astronomers.
Instead of the stars, neuroscientists will be able to see biological systems.
“The new microscope will allow scientists to see for the first time incredibly small features of cells deep within tissues or tumors,” says Michael Dyer, PhD, Developmental Neurobiology chair at St. Jude Children’s Research Hospital.
St. Jude developmental neurobiologists David Solecki, PhD, and Daniel Stabley, PhD, recently acquired a first-generation LLSM for the department’s Neuroimaging Laboratory, a core resource comprising neurobiologists, imaging experts and data scientists. The resolution of this equipment surpasses that of conventional light microscopes. The current LLSM also uses less laser light than other microscopes. Laser light can be toxic to delicate cells.
“The next-generation LLSM will allow scientists to see cellular dynamics with extraordinary clarity,” Solecki says. Dyer, Solecki and Stabley are working with teams at three external labs on the project, the brainchild of Nobel laureate Eric Betzig, PhD, from the University of California, Berkeley.
Like a multi-tool, the next-generation LLSM will smoothly switch from one mode to another, permitting scientists to select different tools derived from decades of technological advancements. St. Jude scientists may one day develop targeted therapies for life-threatening childhood diseases using this technology.
For years, Dyer has studied retinoblastoma, a type of eye cancer that affects young children. When the teams of scientists in this project complete their work, he expects to gain new insight into the biological systems that underpin retinoblastoma—thanks to this handy, high-tech tool.
From Promise, Winter 2020
Thank you for your feedback!
More articles from this issue
-
Paws at Play: A Message from Puggle
Therapy dogs in the St. Jude Paws at Play program make the day a little easier for patients—whether helping them relax during procedures, demonstrating how to take medicine or climbing on a mock scanner to show them MRIs aren’t scary.
-
An Added Boost for Medulloblastoma: SJELIOT
SJELIOT, a St. Jude-led clinical trial for medulloblastoma, tests prexasertib, a drug that enhances the power of other chemotherapies.
-
Cancer Survivors Build Bridge to a Healthy Future
St. Jude helps childhood cancer survivors take control of their health by building lifelong relationships with their primary care providers.
-
Minds Over Matter: St. Jude Research Collaboratives
The St. Jude Research Collaboratives unite global experts from many different institutions to answer outstanding scientific questions.
-
Soft Landings with the Transition Oncology Program
The new Transition Oncology Program (TOP) provides support and education to families whose children are returning home after cancer therapy.
-
LANDO Discovery Has Implications for Cancer Immunotherapy and Alzheimer’s Disease
Activating LANDO, or LC3-associated endocytosis, appears to offer protection against neurodegenerative disease and guard against toxic neuroinflammation and neurodegeneration, including memory problems.
-
Sharing Data Worldwide
St. Jude is helping drive a new age of information-sharing, providing a roadmap for investigators complete with data, tools and resources. By using sophisticated technology, St. Jude shares this data with the global community.
-
Life after St. Jude: We are the Champions
Everyone wins when childhood cancer survivors volunteer to help tomorrow’s patients through St. Jude LIFE, the hospital’s long-term follow-up study.
-
R is for Robot: Automating Drug Screening
Scientists in the High-Throughput Bioscience Center use robots to automate the screening of hundreds of thousands of compounds to discover potential new drugs.
-
Art for ALL
Even the coldest winter day is glorious in the area between Chili’s Care Center and the Kay Research and Care Center. Ducks paddle across brilliant blue water as 1.2 million sequins shimmer in the breeze.
-
News & Highlights - Winter 2020
Learn about the latest discoveries and achievements at St. Jude: the structure of chaperones, flu vaccine news, exercise benefits, TOTAL 16 clinical trial for leukemia, 3D map of the genome, and more.